Authorised representative (AR)

True Standard Limited

Hong Kong MDACS·15 represented devices·1 applicant·May 21, 2024 – Sep 24, 2024

Total devices

Applicants

2024

First representation

2024

Most recent

AR overview

Bilingual authorised representative information and contact details

Authorised representative (EN): True Standard Limited
Phone: 26969558

Timeline

First representation: May 21, 2024
Most recent: Sep 24, 2024

Risk class distribution

Applicant partnerships

Top manufacturers represented by this AR

NuMED, Inc.

Recent registrations

Latest 15 MDACS listings represented by True Standard Limited

Device	Risk class	Applicant	Registered
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 24, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 24, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 24, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 20, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 02, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Sep 02, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Aug 08, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Aug 08, 2024
Catheters, Cardiac 导管,心脏	IV	NuMED, Inc. Numed, Inc.	Aug 08, 2024
Catheters, Cardiac 导管,心脏	IV	NuMED, Inc. Numed, Inc.	Aug 08, 2024
Catheters, Cardiac, Valvuloplasty 导管、心脏导管、瓣膜成形术	IV	NuMED, Inc. Numed, Inc.	Aug 08, 2024
Stent/Grafts, Vascular, Aortic 支架/移植物,血管,主动脉	IV	NuMED, Inc. Numed, Inc.	Jul 23, 2024
Stent/Grafts, Vascular, Aortic 支架/移植物,血管,主动脉	IV	NuMED, Inc. Numed, Inc.	Jul 11, 2024
Catheter Introducers, Vascular, Central Venous, Hemostasis Valve 导管介绍器、血管、中心静脉、止血阀	II	NuMED, Inc. Numed, Inc.	Jul 11, 2024
Catheters, Vascular, Stent Delivery, Aorta 导管、血管、支架输送、主动脉	IV	NuMED, Inc. Numed, Inc.	May 21, 2024

About this profile

True Standard Limited serves as the authorised representative for 15 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.